Vanguard Group’s Avidity Biosciences RNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $263M | Buy |
9,248,302
+5,097
| +0.1% | +$145K | ﹤0.01% | 1376 |
|
|
2025
Q1 | $273M | Sell |
9,243,205
-188,706
| -2% | -$5.57M | ﹤0.01% | 1325 |
|
|
2024
Q4 | $274M | Buy |
9,431,911
+205,027
| +2% | +$5.96M | ﹤0.01% | 1385 |
|
|
2024
Q3 | $424M | Buy |
9,226,884
+3,283,202
| +55% | +$151M | 0.01% | 1131 |
|
|
2024
Q2 | $243M | Buy |
5,943,682
+2,098,610
| +55% | +$85.7M | ﹤0.01% | 1392 |
|
|
2024
Q1 | $98.1M | Sell |
3,845,072
-198,107
| -5% | -$5.06M | ﹤0.01% | 1877 |
|
|
2023
Q4 | $36.6M | Buy |
4,043,179
+28,689
| +0.7% | +$260K | ﹤0.01% | 2318 |
|
|
2023
Q3 | $25.6M | Buy |
4,014,490
+47,305
| +1% | +$302K | ﹤0.01% | 2451 |
|
|
2023
Q2 | $44M | Buy |
3,967,185
+485,468
| +14% | +$5.38M | ﹤0.01% | 2239 |
|
|
2023
Q1 | $53.4M | Buy |
3,481,717
+11,091
| +0.3% | +$170K | ﹤0.01% | 2145 |
|
|
2022
Q4 | $77M | Buy |
3,470,626
+772,250
| +29% | +$17.1M | ﹤0.01% | 1948 |
|
|
2022
Q3 | $44.1M | Buy |
2,698,376
+276,254
| +11% | +$4.51M | ﹤0.01% | 2243 |
|
|
2022
Q2 | $35.2M | Buy |
2,422,122
+123,759
| +5% | +$1.8M | ﹤0.01% | 2362 |
|
|
2022
Q1 | $42.5M | Buy |
2,298,363
+294,791
| +15% | +$5.44M | ﹤0.01% | 2384 |
|
|
2021
Q4 | $47.6M | Buy |
2,003,572
+60,959
| +3% | +$1.45M | ﹤0.01% | 2381 |
|
|
2021
Q3 | $47.8M | Buy |
1,942,613
+670,815
| +53% | +$16.5M | ﹤0.01% | 2385 |
|
|
2021
Q2 | $31.4M | Sell |
1,271,798
-11,273
| -0.9% | -$279K | ﹤0.01% | 2610 |
|
|
2021
Q1 | $28M | Buy |
1,283,071
+468,745
| +58% | +$10.2M | ﹤0.01% | 2610 |
|
|
2020
Q4 | $20.8M | Buy |
814,326
+65,055
| +9% | +$1.66M | ﹤0.01% | 2614 |
|
|
2020
Q3 | $21.1M | Buy |
749,271
+729,271
| +3,646% | +$20.5M | ﹤0.01% | 2436 |
|
|
2020
Q2 | $565K | Buy |
+20,000
| New | +$565K | ﹤0.01% | 3743 |
|